Tin-protoporphyrin in the management of children with Crigler-Najjar disease.
McDonagh
A F
AF
D003414:Crigler-Najjar Syndrome / Q000188:drug therapy* / Q000378:metabolism; D004341:Drug Evaluation; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary / Q000188:drug therapy*; D007231:Infant, Newborn; D008665:Metalloporphyrins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010787:Photosensitivity Disorders / Q000139:chemically induced; D011166:Porphyrins / Q000627:therapeutic use*; D011524:Protoporphyrins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D008665:Metalloporphyrins; D011166:Porphyrins; D011524:Protoporphyrins; C032628:tin protoporphyrin IX